Topical Ruxolitinib is More Effective at Itch Reduction than Topical Roflumilast in Atopic Dermatitis: A Comparative Meta-Analysis

Name: Topical Ruxolitinib is More Effective at Itch Reduction than Topical Roflumilast in Atopic Dermatitis: A Comparative Meta-Analysis
Creator: Grace Xiong
Published: 2025-05-19T17:53:03.980Z
Keywords: Meta-Analysis

Xiong, Grace

doi:10.17632/8x99n3v5m3.2

Topical Ruxolitinib is More Effective at Itch Reduction than Topical Roflumilast in Atopic Dermatitis: A Comparative Meta-Analysis

Published: 19 May 2025| Version 2 | DOI: 10.17632/8x99n3v5m3.2

Contributor:

Grace Xiong

Description

Supplemental figures and data for study titled "Topical Ruxolitinib is More Effective at Itch Reduction than Roflumilast: A Comparative Meta-Analysis".

Topical Ruxolitinib is More Effective at Itch Reduction than Topical Roflumilast in Atopic Dermatitis: A Comparative Meta-Analysis

Description

Files

Categories

Licence